Literature DB >> 11858476

The role of alpha(v)beta3 integrins in vascular healing.

Mansoor Sajid1, George A Stouffer.   

Abstract

Alpha(v)beta3 integrins play an important role in vascular healing. Vascular injury is a stimulus for expression of alpha(v)beta3 by vascular cells and, among other effects, alpha(v)beta3 integrins function in the adhesion of activated platelets to endothelium. white cell/endothelium interactions, platelet-mediated thrombin generation, fibrin clot retraction by nucleated cells, smooth muscle cell (SMC) migration and proliferation, vascular cell apoptosis, and vascular remodeling. There are ten different animal models in which treatment with alpha(v)beta3 antagonists reduced the vascular response, including (neo)intima formation, after mechanical injury. These studies, along with mechanistic data derived from cell culture studies, provide compelling evidence that alpha(v)beta3 integrins are involved in vascular repair processes. The challenge is to develop a therapeutic agent that will prove effective in reducing restenosis in humans following percutaneous coronary intervention (PCI).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11858476

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  12 in total

1.  Copper dependence of angioproliferation in pulmonary arterial hypertension in rats and humans.

Authors:  Harm J Bogaard; Shiro Mizuno; Christophe Guignabert; Aysar A Al Hussaini; Daniela Farkas; Gerrina Ruiter; Donatas Kraskauskas; Elie Fadel; Jeremy C Allegood; Marc Humbert; Anton Vonk Noordegraaf; Sarah Spiegel; Laszlo Farkas; Norbert F Voelkel
Journal:  Am J Respir Cell Mol Biol       Date:  2011-12-28       Impact factor: 6.914

Review 2.  Optimal use of platelet glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions.

Authors:  H Benjamin Starnes; Ankit A Patel; George A Stouffer
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

3.  RGD-dependent binding of TP508 to integrin alphavbeta3 mediates cell adhesion and induction of nitric oxide.

Authors:  Dmitry N Derkach; Subhagya A Wadekar; Kim B Perkins; Emma Rousseau; Catherine M Dreiza; Joyce Cheung-Flynn; Heidi C Ramos; Tatiana P Ugarova; Michael R Sheller
Journal:  Thromb Haemost       Date:  2010-05-27       Impact factor: 5.249

Review 4.  The pathobiology of the vessel wall: implications for imaging.

Authors:  Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

Review 5.  Advances in alloimmune thrombocytopenia: perspectives on current concepts of human platelet antigens, antibody detection strategies, and genotyping.

Authors:  Tomoya Hayashi; Fumiya Hirayama
Journal:  Blood Transfus       Date:  2015-04-30       Impact factor: 3.443

Review 6.  Nanoimaging in cardiovascular diseases: Current state of the art.

Authors:  Suryyani Deb; Kanjaksha Ghosh; Shrimati Dharmapal Shetty
Journal:  Indian J Med Res       Date:  2015-03       Impact factor: 2.375

7.  Sca-1 is involved in the adhesion of myosphere cells to αVβ3 integrin.

Authors:  Ashley Penvose; Karen A Westerman
Journal:  Biol Open       Date:  2012-07-09       Impact factor: 2.422

8.  Eptifibatide and abciximab inhibit insulin-induced focal adhesion formation and proliferative responses in human aortic smooth muscle cells.

Authors:  Alokkumar Pathak; Renyi Zhao; Jianhua Huang; George A Stouffer
Journal:  Cardiovasc Diabetol       Date:  2008-12-23       Impact factor: 9.951

Review 9.  Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics.

Authors:  Trung D Tran; Shelton D Caruthers; Michael Hughes; John N Marsh; Tillmann Cyrus; Patrick M Winter; Anne M Neubauer; Samuel A Wickline; Gregory M Lanza
Journal:  Int J Nanomedicine       Date:  2007

10.  Transcriptomic characterization of the dorsal lobes after hepatectomy of the ventral lobe in zebrafish.

Authors:  Guohui Feng; Yong Long; Jinrong Peng; Qing Li; Zongbin Cui
Journal:  BMC Genomics       Date:  2015-11-19       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.